Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DULOXETINE vs DURVALUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DULOXETINE vs DURVALUMAB: Safety Overview

Metric DULOXETINE DURVALUMAB
Total FAERS Reports 52,188 17,142
Deaths Reported 4,044 5,088
Death Rate 7.7% 29.7%
Hospitalizations 10,622 5,968
Average Patient Age 52.7 yrs 65.7 yrs
% Female Patients 72.9% 35.1%
FDA Approval Date Apr 17, 2019 N/A
Manufacturer Macleods Pharmaceuticals Limited AstraZeneca Pharmaceuticals LP
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription